association of hyperhomocysteinemia with coronary artery disease in southern iran

Authors

j golbahar

abstract

dear editor,   in response to the criticisms regarding the article entitled; “association of hyperhomocysteinemia with coronary artery disease in southern iran”, published in iran j med sci, 1 we still believe the methodology used in this study was a case control design as the cases where chosen on the basis of outcome (coronary artery disease) and the controls were individuals without the disease or outcome. in this study the individual affected by coronary artery disease were compared with a control group of unaffected individuals. the history of both cases and controls were analyzed to identify the characteristic and risk associated with hyperhomocystenemia present in the cases. regarding the relative risk terminology we agree with the critics that perhaps the “estimate or approximate relative risk” would have been a better terminology to use in this case control study rather than relative risk. we also agree with the critics that cohort study would have been a better option but the estimate relative risk derived from the case control studies often agree with those obtained from the cohort studies.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Association of Hyperhomocysteinemia with Coronary Artery Disease in Southern Iran

Background: Differences in the prevalence and impact of hyperhomocytenemia on vascular disease between countries and races have been reported. Most studies have been undertaken in North American and European populations and the importance of plasma total homocysteine (tHcy) level as a risk factor for coronary artery disease in the Middle East particularly in Iran, however, is not known.  Object...

full text

Association of hyperhomocysteinemia with coronary artery disease in southern Iran

Dear Editor, In response to the criticisms regarding the article entitled; “association of hyperhomocysteinemia with coronary artery disease in Southern Iran”, published in Iran J Med Sci,1 we still believe the methodology used in this study was a case control design as the cases where chosen on the basis of outcome (coronary artery disease) and the controls were individuals without the disease...

full text

Association Study of rs1333040 and rs1004638 Polymorphisms in the 9p21 Locus with Coronary Artery Disease in Southwest of Iran

Background: Coronary artery disease (CAD) is a multifactorial and heterogenic disease. Recently, genome-wide association studies have reported that rs1333040 (C/T) and rs1004638 (A/T) single nucleotide polymorphisms (SNPs) in the 9p21 locus have very strong association with CAD. This study aimed to examine these associations in Southwest of Iran. Methods: Blood samples were collected from 200 C...

full text

CYP2C19 Genetic Polymorphism in the East of Iran: Its Association with the Severity and Pattern of Coronary Artery Disease

Introduction: Since there has been a dearth of research on the assessment of CYP2C19 polymorphism in the east of Iran (Khorasan provinces), this study aimed to detect, CYP2C19*2 and CYP2C19*3 allele frequencies among patients with coronary artery disease. The participants were selected among those referring to Emam Reza Hospital, Mashhad, Iran. Furthermore, the current research was motivated to...

full text

Association Study of rs3184504 C>T Polymorphism in Patients With Coronary Artery Disease

Cardiovascular disease has become the main factor of death and birth defects in the world and also in Iran. New clinical studies have shown that early diagnosis of patients with coronary artery disease (CAD) can contribute to effective prevention or therapeutic structures, which reduce mortality or the next chance of cardiovascular events, and increase the quality of life. Most studies on CAD d...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of medical sciences

جلد ۳۰، شماره ۱، صفحات ۴۹-۰

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023